Published 25 June 2023 Håkan Axelson's research group is part of the large EU-funded KATY project, which focuses on the most common type of kidney cancer, clear cell renal cell carcinoma, which is one of the ten most common types of cancer worldwide. Image: iStock. What happens when you mix a group of tumor biology researchers with software developers and AI researchers? Hopefully, with the help o

https://www.lucc.lu.se/article/kicking-kidney-cancer - 2025-03-05

Published 2 October 2023 Kristina Lång (Photo: Erika Svantesson) Mammography screening supported by artificial intelligence (AI) is a safe alternative to today’s conventional double reading by radiologists and can reduce heavy workloads for doctors. This has now been shown in an interim analysis of a prospective, randomised controlled trial, which addressed the clinical safety of using AI in mammo

https://www.lucc.lu.se/article/ai-supported-mammography-screening-found-be-safe - 2025-03-05

Published 2 October 2023 Image: iStock/Rasi Bhadramani BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of hereditary breast and ovarian cancer. However, there are an additional eleven genes associated with elevated risk for these types of cancer. A multi-year Swedish study now reveals that the proportion of women with genetically confirmed heredita

https://www.lucc.lu.se/article/breast-cancer-study-altered-guidelines-sweden - 2025-03-05

Published 5 October 2023 UroCan – LUCC: translational cancer research network explains their research in a film. Film on YouTube Bladder cancer research group at Lund University Cancer Centre explains the importance of research done in the past years. What is the future of bladder cancer diagnosis and treatment? Did you know you can directly contact the research centre if you experience bladder ca

https://www.lucc.lu.se/article/urinary-bladder-cancer-research - 2025-03-05

Published 4 March 2024 The government has appointed Professor Mef Nilbert as a special investigator with the task of submitting proposals for an updated national cancer strategy. The updated strategy is the next step in developing the existing strategy that was presented in 2009, but is adapted to address the major developments that have taken place in cancer care since then. The update is made to

https://www.lucc.lu.se/article/mef-nilbert-leads-update-new-swedish-cancer-strategy - 2025-03-05

Published 24 April 2024 The research group in front of the Faculty of Medicine's donation tree. From left: Juliet Jacobsen, Eva Brun, Jenny Klintman and Mikael Segerlantz The Department of Clinical Sciences, Medical Oncology, in Lund, one of six departments at the Faculty of Medicine and the largest at the Lund University, has received a significant financial boost thanks to an anonymous donor. Th

https://www.lucc.lu.se/article/donation-research-early-hospital-based-palliative-care - 2025-03-05

Published 8 August 2024 Possible association between tattoos and lymphoma revealed A new study from Lund University in Sweden suggests that tattoos could be a risk factor for cancer in the lymphatic system, or lymphoma. Now, the researchers underline the need for more research on the topic. Our knowledge regarding the long-term health effects of tattoos is currently poor, and there is not a lot of

https://www.lucc.lu.se/article/possible-association-between-tattoos-and-lymphoma-revealed - 2025-03-05

Published 8 August 2024 Simon Boas, who wrote a candid account of living with cancer, passed away on July 15 at the age of 47. In a recent BBC interview, the former aid worker told the reporter: “My pain is under control and I’m terribly happy – it sounds weird to say, but I’m as happy as I’ve ever been in my life.”It may seem odd that a person could be happy as the end draws near, but in my exper

https://www.lucc.lu.se/article/why-are-some-people-happy-when-they-are-dying - 2025-03-05

Published 12 August 2024 Filipe Pereira and Per Augustsson have been awarded Proof of Concept grants. Photos: Håkan Röjder and Kennet Ruona Per Augustsson at LTH and Filipe Pereira at the Faculty of Medicine have been awarded Proof of Concept grants from the European Research Council (ERC) in the first round of 2024. The ERC today announced 100 new Proof of Concept grants, of which a total of thre

https://www.lucc.lu.se/article/researchers-receive-prestigious-erc-grant - 2025-03-05

Published 14 February 2025 Foam cells visualised using confocal microscopy in tissue from a patient with glioblastoma. Shown are the nucleus (in blue), a marker for macrophages that are recruited from the bone marrow (in green) and lipid droplets that gave the foam cell its name. A research team at Lund University in Sweden has discovered a certain type of cells – foam cells – in patients with the

https://www.lucc.lu.se/article/foam-cells-brain-tumours - 2025-03-05

Published 27 February 2025 The Mrs Berta Kamprad Foundation is donating SEK 420 million to cancer research at Lund University. This is the largest donation to the university since its foundation in 1666. The donation is dedicated to translational cancer research, meaning applied cancer research in antibody and cell therapies with the aim of improving prognosis and quality of life for today's cance

https://www.lucc.lu.se/article/sek-420-million-cancer-research-lund-university - 2025-03-05

Published 4 July 2019 Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden’s most common forms of cancer. A research team at Lund University in Sweden has studied a protein that regulates a gene which is linked to metastasis of malignant mel

https://www.lucc.lu.se/article/protein-linked-aggressive-skin-cancer - 2025-03-05

Published 23 August 2019 The first evidence was recently presented demonstrating how the immune system can be controlled by directly reprogramming connective tissue cells into immune cells. The discovery provides the opportunity to develop an entirely new strategy for targeted immunotherapy against cancer. Filipe Pereira, research team leader and Molecular Medicine Fellow at the Wallenberg Centre

https://www.lucc.lu.se/article/research-project-develop-innovative-strategy-cancer-therapy - 2025-03-05

Published 24 September 2019 In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalised treatment of lymph nodes in breast cancer patients. The latest results that have now been published in Clinical Cancer Research and BMC Cancer show that up to one in every three operations could be avoided. P

https://www.lucc.lu.se/article/fewer-lymph-node-operations-breast-cancer-patients-new-prediction-models - 2025-03-05

Published 26 September 2019 In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. The study, published in the British Medical Journal, includes over one million Swedish men. “Men who seek health care for infertility and assisted reproduction were shown to be at higher risk for prostate cancer than those who had b

https://www.lucc.lu.se/article/link-between-assisted-reproduction-and-risk-prostate-cancer - 2025-03-05

Published 11 October 2019 Lund researchers Anna Sundlöv and Katarina Sjögreen-Gleisner have developed a method to personalise treatment using a newly approved radioactive cancer drug – by taking images of the drug’s dispersion inside the patient. Their article won the best publication of the year prize awarded by the journal EJNMMI Physics. 177Lutetium-DOTATATE one day after injection (coloured ar

https://www.lucc.lu.se/article/researchers-lund-receive-prize-publication-year - 2025-03-05

Published 12 December 2019 Triple negative breast cancer is an aggressive type of cancer representing approximately nine percent of all breast cancer cases in Sweden. It is more common among younger women, has a high heredity factor and causes more frequent relapses earlier in the course of the disease than other breast cancers. Researchers have applied full genome sequencing to carry out detailed

https://www.lucc.lu.se/article/patient-specific-diagnostics-breast-cancers-are-difficult-cure - 2025-03-05

Published 12 December 2019 Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the patient will react to therapy. She has now received an aw

https://www.lucc.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2025-03-05

Published 7 January 2020 The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Sweden is one of the 89 selected researchers, and will be awa

https://www.lucc.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2025-03-05

Published 3 February 2020 Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. B cells linked to effective cancer immunotherapyCancer patients responded better to immunotherapy and had a better prognosis if their melan

https://www.lucc.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-03-05